S. Raimondo

Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis

P. Tak, D. Gerlag, L. Yeo, 2011, Annals of the rheumatic diseases.

Interleukin (IL)‐22 receptor 1 is over‐expressed in primary Sjogren's syndrome and Sjögren‐associated non‐Hodgkin lymphomas and is regulated by IL‐18

S. Raimondo, G. Sireci, F. Dieli, 2015, Clinical and experimental immunology.

Citrus limon-derived nanovesicles inhibit cancer cell proliferation and suppress CML xenograft growth by inducing TRAIL-mediated cell death

S. Raimondo, Giovanni Zito, L. Saieva, 2015, Oncotarget.

Interleukin‐36α axis is modulated in patients with primary Sjögren's syndrome

C. Alessandri, S. Raimondo, R. Priori, 2015, Clinical and experimental immunology.